IFN-γ Reporter HEK 293 Cells
HEK-Blue™ IFN-γ cells | Unit size | Cat. code | Docs | Qty | Price |
---|---|---|---|---|---|
Human HEK293 cells - IFN-γ Reporter Cells |
3-7 x 10e6 cells |
hkb-ifng |
You may also need : QUANTI-Blue™ | View more associated products ▼
Human Interferon-γ Reporter Cells
HEK-Blue™ IFN-γ Cells signaling pathway
HEK-Blue™ IFN-γ cells allow the detection of bioactive human IFN-γ by monitoring the activation of the JAK/STAT-1 pathway.
HEK-Blue™ IFN-γ cells produce SEAP in response to IFN-γ stimulation only. They are unresponsive to type I IFNs.
Levels of SEAP in the supernatant can be easily determined with QUANTI-Blue™ Solution.
Features of HEK-Blue™ IFN-γ cells:
- Fully functional IFN-γ signaling pathway
- Readily assessable SEAP reporter activity
- Functionally tested and guaranteed mycoplasma-free
Applications of HEK-Blue™ IFN-γ cells:
- Detection of human IFN-γ
- Screening of anti-IFN-γ antibodies
Specifications
Antibiotic resistance: blasticidin, Zeocin™
Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™
Guaranteed mycoplasma-free
Detection range for human IFN-γ: 5 - 100 IU/ml
Back to the topContents
- 1 vial containing 3-7 x 106 cells
- 1 ml of blasticidin (10 mg/ml)
- 1 ml of Zeocin™ (100 mg/ml)
- 1 ml of Normocin™ (50 mg/ml)
- 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
Shipped on dry ice (Europe, USA & Canada)
Details
HEK-Blue™ IFN-γ cells were generated by stable transfection of HEK293 cells with the human STAT1 gene to obtain a fully active STAT1 pathway.
The other genes of the pathway are naturally expressed in sufficient amounts.
The cells were further transfected with a SEAP reporter gene under the control of an ISG54 promoter fused to four interferon-gamma-activated sites (GAS).
HEK-Blue™ IFN-γ cells produce SEAP in response to IFN-γ stimulation only. They are unresponsive to type I IFNs.
IFN-γ exerts its action by first binding to a heterodimeric receptor consisting of two chains, IFNGR1 and IFNGR2, causing its dimerization and the activation of specific Janus family kinases (JAK1 and JAK2).
Two STAT1 molecules then associate with this ligand-activated receptor complex and are activated by phosphorylation.
Activated STAT1 form homodimers and are translocated to the nucleus where they bind interferon-gamma-activated sites (GAS) in the promoter of IFN-γ inducible genes.
Back to the top